EF
eFFECTOR Therapeutics, Inc.
EFTR · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $940.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/FCF N/A
P/E N/A
EV/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 221.30%
ROA 174.31%
Debt
23 /100
High Current ratio 0.77x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
1 /100
Unstable EPS volatility 5,672.23%
Beta 2.48x
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na EFTR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig R. Jalbert
Employees
14
Headquarters
Solana Beach
Nadcházející události
17 LIS
Earnings
Upcoming earnings report